期刊名称：INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Description
The International Journal of Infectious Diseases (IJID) is the official publication of the International Society for Infectious Diseases and is now published on a bi-monthly basis. The Journal aims to provide a source of information relevant to professionals involved in the epidemiology, clinical diagnosis, treatment and control of infectious diseases with particular emphasis placed on those disease which are most common in less-developed countries.
IJID publishes original clinical and laboratory-based research, together with reports of clinical trials, reviews and some case reports.
Instructions to Authors
The International Journal of Infectious Diseases (IJID) is published bimonthly by the International Society for Infectious Diseases. IJID welcomes manuscripts in the following categories:
Original articles on infectious disease topics of broad interest. We particularly welcome papers that discuss epidemiological aspects of international health, clinical reports, clinical trials and reports of laboratory investigations. Case reports must be carefully documented and must be of importance because they illustrate or describe unusual features or have important therapeutic implications. They should include a brief but complete review of the relevant literature. In most instances, case reports will be published in the Correspondence columns. Original articles should not exceed 5000 words in length.
Reviews on topics of importance to readers in diverse geographic areas. These should be comprehensive and fully referenced. Maximum length 6000 words.
Perspectives are papers that advance a hypothesis or represent an opinion relating to a topic of current interest or importance. They should be fully referenced, and should not exceed 2000 words in length.
Correspondence relating to papers recently published in the Journal, or containing brief reports of unusual or preliminary findings. Case reports of interest will also be accepted for this section. Maximum length 400 words, one table or figure and a maximum of 10 references.
Manuscript Submission
Manuscripts should be submitted online at: http://authors.elsevier.com/ijid
Covering letter: Manuscripts must be accompanied by a covering letter signed by ALL the authors stating that the current "Instructions to Authors" have been read, thereby indicating compliance with those instructions and acceptance of the conditions posed. The letter should state that the authors have seen and agreed to the submitted version of the paper, that all who have been acknowledged as contributors or as providers of personal communications have agreed to their inclusion, that the material is original and that it has been neither published elsewhere nor submitted for publication simultaneously. In addition the letter should state that if accepted, the paper will not be published elsewhere in the same form, in English or in any other language, without written consent of the copyright holder.
A scanned image of the signed covering letter should be submitted via the online submission system. If this is not possible the letter should be posted or faxed to the Editorial Office.
Conflict of Interest: manuscripts cannot be published until we have received a signed Conflict of Interest Declaration form. You may obtain a Conflict of Interest Declaration document to be completed from the link below or upon request from the IJID Editorial Office ijid@bsms.ac.uk. You are strongly advised to provide the declaration at the time you first submit your paper. A scanned image of the signed declaration should be submitted via the online submission system. If this is not possible the declaration should be posted or faxed to the Editorial Office.
Conflict of Interest Declaration (pdf format) [To read the PDF file you must have Adobe Acrobat Reader installed on your system. Download a free copy of Adobe Acrobat Reader. http://www.adobe.com/products/acrobat/readstep2.html]
Upon acceptance for publication, manuscripts will become the permanent property of the International Society for Infectious Diseases and may not be published elsewhere without the permission of the Society.
Manuscript format
General: The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. Do not embed 'graphically designed' equations or tables, but prepare these using the wordprocessor's facility.
When preparing tables, preferably use a table grid and use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Author Gateway's Quickguide: http://authors.elsevier.com). Do not import the figures into the text file but instead, indicate their approximate locations directly in the electronic text. Each figure must be submitted separately as requested at the file upload stage of submission. For further information on the preparation of electronic illustrations, please refer to the "Tables and Figures" section.
To avoid unnecessary errors you are strongly advised to use the 'spellchecker' function of your wordprocessor.
The entire manuscript, including the abstract, acknowledgements, references, tables, figures, and legends, must be double spaced, with a margin of at least 2.5 cm. On assignment to an editor, each manuscript will be assigned a number, which will be provided to the author. The author should refer to this number in all ensuing correspondence. All manuscripts (including correspondence) will be subject to peer review. A rapid response to the authors will be more feasible if the manuscript is prepared as stipulated in the Instructions to Authors. Expressions of Latin origin, for example, in vivo, et al., per se should not be in italics. Articles must be written in English. Authors in Japan kindly note that, upon request, Elsevier Japan will provide a list of people who can check and improve the English of an article before submission. Contact our Tokyo office: Elsevier Japan, 4F Higashi-Azabu, 1-Chome Bldg, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan, Tel.: (+81) (3) 5561 5037; Fax: (+81) (3) 5561 5047; e-mail: jp.info@elsevier.com
Numbers and measurements: Use decimal points (not commas); use a space for thousands (10 000 and above).
Title Page: The title page must include each author's full name and academic affiliations. The author to whom correspondence concerning the manuscript and to whom requests for reprints should be directed must be designated, as well as the corresponding address, telephone, fax, and e-mail. Manuscripts that were presented as part of a meeting must include the title, location, and date of the meeting on the title page. Abstract: A structured abstract of 150 to 200 words must be provided as part of each manuscript, except correspondence. The abstract should consist of four paragraphs, labelled with the following headings: objectives, design or methods, results, conclusions, or alternative headings appropriate to the format of the paper. The abstract should not refer to footnotes or references.
Keywords: Immediately after the abstract, provide a maximum of six keywords, avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be used.
Acknowledgements: Place acknowledgements, including information on grants received, before the references, in a separate section, and not as a footnote on the title page.
References: Indicate references by superscript numbers in the text.
Number the references in the list in the order in which they appear in the text.
Examples:
Reference to a journal publication:
1. Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 2000;163:51-9.
Reference to a book:
2. Strunk Jr W, White EB. The elements of style. 3rd ed. New York: Macmillan; 1979. Reference to a chapter in an edited book:
3. Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 1999, p. 281-304.
Note shortened form for last page number. e.g., 51-9, and that for more than six authors the first six should be listed followed by 'et al.' For further details you are referred to "Uniform Requirements for Manuscripts submitted to Biomedical Journals" (J Am Med Assoc 1997;277:927-934) (see also http://www.nejm.org/general/text/requirements/1.htm) References to personal communications and to unpublished material must be incorporated, in parentheses, at the appropriate place in the text. References to congress abstracts should be cited in the reference section if they have been published previously in an official book of abstracts from the congress; otherwise they should be incorporated in the text. The author is responsible for the accuracy and completeness of the references.
Citing and listing of web references: Such article citations should include the DOI (digital object identifier).
For example:
Boutayeb A, Twizell EH, Achouayb K, Chetouani A. A mathematical model for the burden of diabetes and its complications. Biomed Eng Online 2004;3:20. doi:10.1186/1475-925X-3-20. The DOI is a persistent identifier, which remains with the article even after it is published in print. See http://www.doi.org for details.
If the reference does not have a DOI, the full URL should be given. Any further information, if known (author names, dates, reference to a source publication, etc.), should also be given.
Style: For stylistic questions, authors are referred to the Chicago Manual of Style, 14th Edition, 1993, published by the University of Chicago Press.
Abbreviations: Abbreviations in the text are discouraged. If a term appears repeatedly, however, an abbreviation may be introduced parenthetically at the initial mention of the term and used thereafter in place of the term. Abbreviations of conventional or SI units of measurement may be used without introduction.
References to drugs: The generic name of a drug should be used as a general rule; however, the full name or the commercial name of the drug, as well as the name and location of the supplier, may be given in addition if appropriate.
Tables and Figures: Data reported either in a table or in a figure should be illustrative of information reported in the text, but should not be redundant with the text. Each table must be presented at the end of the manuscript on a separate page and numbered in order of appearance in the text. The title of the table must appear after the number. Each table must include appropriate headings. Footnotes, when necessary, must be identified by letters. Units of measurement must be clearly indicated.
Figures should not be imported into the manuscript text file but submitted separately as requested at the file upload stage of submission. A short detailed legend should be provided for each figure. All legends must be collected together on a separate page following the body of the manuscript.
If, together with your accepted article, you submit usable colour figures then we will ensure, at no additional charge, that these figures will appear in colour on the web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. For further information on the preparation of electronic artwork, please see http://authors.elsevier.com/artwork.
Please note: Because of technical complications which can arise by converting colour figures to 'grey scale' (for the printed version should you not opt for colour in print) please submit in addition usable black and white prints corresponding to all the colour illustrations.
Photomicrographs should include a micron bar or other appropriate scale marking.
Bacterial nomenclature: Microbes should be referred to by their scientific names according to the binomial system used in the latest edition of Bergey's Manual of Systematic Bacteriology (The Williams and Wilkins Co.). When first mentioned, the name should be in full and written in italics. Thereafter, the genus should be abbreviated to its initial letter, e.g. 'S. aureus' not 'Staph. Aureus'. If abbreviation is likely to cause confusion or render the intended meaning(s) unclear the names of organisms should be given in full. Only those names included in the Approved Lists of Bacterial Names (Int J Syst Bacteriol 1980; 30: 225-420) and/or which have been validly published in the Int J Syst Bacteriol since January 1980 are acceptable. If there is a good reason to use a name that does not have standing in nomenclature, it should be enclosed in quotation marks and an appropriate statement concerning its use made in the text (e.g. Int J Syst Bacteriol 1980; 30: 547-556).
Symbols for units of measurement must accord with the Système International (SI): However, blood pressure should be expressed in mmHg and haemoglobin as g/dl.
GenBank/DNA sequence linking: Many Elsevier journals cite "gene accession numbers" in their running text and footnotes. Gene accession numbers refer to genes or DNA sequences about which further information can be found in the databases at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine. Elsevier authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources, should type this information in the following manner:
For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalised. (See example below). This combination of letters and format will enable Elsevier's typesetters to recognise the relevant texts as accession numbers and add the required link to GenBank's sequences.
Example: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)".
Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link. In the final version of the printed article, the accession number text will not appear bold or underlined. In the final version of the electronic copy, the accession number text will be linked to the appropriate source in the NCBI databases enabling readers to go directly to that source from the article.
Supplementary material submission. Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our Author Gateway at http://authors.elsevier.com.
Copyright. Upon acceptance of an article, authors will be asked to transfer copyright (for more information on copyright see http://authors.elsevier.com). This transfer will ensure the widest possible dissemination of information. A letter will be sent to the corresponding author by email, confirming receipt of the manuscript, together with a form facilitating the transfer of copyright. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact ES Global Rights Department, P.O. Box 800, Oxford, OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com
Ethical Consideration. Reports on biomedical research involving human subjects must include a statement that informed consent was obtained from each subject, or from his or her guardian. Reports on human experimentation must include a statement of approval by a local Human Investigations Committee, in accordance with the precepts established by the Helsinki Declaration. Particular care should be taken to ensure that it is not possible to identify an individual patient from a case report or photograph; if in doubt, a signed consent should be provided.
Proofs. One set of page proofs in PDF format will be sent by e-mail to the corresponding author, to be checked for typesetting/editing. No changes in, or additions to, the accepted (and subsequently edited) manuscript will be allowed at this stage. Proofreading is solely the responsibility of the author. A form with queries from the copyeditor may accompany your proofs. Please answer all queries and make any corrections or additions required.
Editorial Board
Editor-in-Chief
Prof Jonathan Cohen
Dean, Brighton & Sussex Medical School
IJID Editorial Office
University of Sussex
Brighton
BN1 9PX
UK
Tel: +44 1273 877578
Fax: +44 1273 877576
Email: ijid@bsms.ac.uk
Editorial Assistant
Jackie Parker
IJID Editorial Office
University of Sussex
United Kingdom
Corresponding Editors
Salim S Abdool Karim
Durban
South Africa
Timothy Barkham
Tan Tock Seng
Singapore
J Peter Donnelly
Nijmegen
The Netherlands
Michael Ellis
Al Ain
UAE
Andy Hoepelman
Utrecht
The Netherlands
Richard A Oberhelman
New Orleans
USA
Raymond Smego
Bethesda
USA
Michael Whitby
Brisbane
Australia
Jane Zuckerman
London
UK
Executive Committee
Francisco Antunes
Portugal
Keryn Christiansen (President)
Australia
Raul Isturiz
Venezuela
Dennis L Kasper (Past President)
USA
Keith Klugman
USA
Carl Erik Nord (Treasurer)
Sweden
Heikki Peltola
Finland
Didier Raoult
France
Jingoro Shimada (Secretary)
Japan
Richard Wenzel (President-elect)
USA
Publications Committee
Jean-Paul Butzler
Jonathan Cohen
Alasdair Geddes
Dennis Kasper (Chair)
Richard Wenzel
Council
Guillermo Acuña
Chile
Awa Aïdara-Kane
Switzerland
Mohammed Benbachir
Morocco
S M Bhatt
Kenya
N C Bodonaik
Jamaica
Rosa Bologna
Argentina
Mary Jane Cardosa
Malaysia
Kang Won Choe
Korea
Ron Dagan
Israel
Adriano G Duse
South Africa
Luiza-Helena Falleiros-Carvalho
Brazil
Roger Finch
UK
Le Dang Ha
Vietnam
Waleria Hryniewicz
Poland
Salah A Ibrahim
Sudan
Moses Kamya
Uganda
Meinoïf Karthaus
Germany
Gustavo Kouri
Cuba
Vladimír Krcmér?BR>Slovak Republic
N Kumarasamy
India
Christopher Lee
Malaysia
Philippe Lepage
Belgium
Daniel Lew
Switzerland
Donald E Low
Canada
Chewe Luo
Zambia
Ziad Memish
Saudi Arabia
Patricia Munoz
Spain
Alaine Nyaruhirira
Belgium
Carla M Odio
Costa Rica
Nobuhiko Okabe
Japan
Andrew Onderdonk
USA
Franco Paradisi
Italy
Mahbubur Rahman
Bangaladesh
Jose Ignacio Santos
Mexico
Atef M Shibl
Saudi Arabia
Leonid Stratchounski
Russia
Zuhayr Tabbarah
Lebanon
Jaime Torres
Venezuela
Thelma Tupasi-Ramos
Philippines
Asda Vibhagool
Thailand
María Virginia Villegas
Columbia
Fu Wang
China
Richard J Whitley
USA
Sin Yew Wong
Singapore
Advisory Board
Awa Marie Aïdara-Kane
Senegal
Keryn Christiansen
Australia
Eduardo Gotuzzo
Peru
King K Holmes
USA
Raúl Istúriz
Venezuela
T Jacob John
India
Keith Klugman
USA
Davy Koech
Kenya
Shigeru Kohno
Japan
Vladimír Krcmér?BR>Slovak Republic
Philippe Lepage
Belgium
Andrew Lever
UK
Andrew Onderdonk
USA
Samuel Ponce de Leon
Mexico
Didier Raoult
France
Rino Rappuoli
Italy
Jae-Hoon Song
Republic of Korea
Tania Sorrell
Australia
Thelma Tupasi-Ramos
Philippines
| 
